Xibrom Approval History

• FDA approved: Yes (First approved March 24th, 2005)
• Brand name: Xibrom
• Generic name: bromfenac
• Company: ISTA Pharmaceuticals, Inc.
• Treatment for: Postoperative Ocular Inflammation

Xibrom (bromfenac) is an ophthalmic nonsteroidal antiinflammatory drug (NSAID) for the treatment of postoperative pain and inflammation in patients who have undergone cataract extraction.

FDA Approval History for Xibrom

Date	Article
Jan 27, 2006	Xibrom - ISTA Pharmaceuticals, Inc. - New Indication Approved
Mar 24, 2005	Xibrom ISTA Pharmaceuticals, Inc. - Treatment for Ocular Inflammation Following Cataract Surgery
Jul 26, 2004	FDA Accepts ISTA Pharmaceuticals' New Drug Application for Xibrom
May 25, 2004	ISTA Pharmaceuticals Announces Submission of Xibrom NDA to the FDA

See also...

Xibrom (bromfenac) Consumer Information

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.